The United Arab Emirates is a top-tier market for MedTech and IVD devices, but entry is strictly controlled by the Ministry of Health and Prevention (MOHAP). In this episode, we explore the common pitfalls and hidden complexities of the MOHAP registration process that often derail even the most experienced manufacturers.

We break down the critical steps, from pre-registering manufacturing sites to compiling a flawless technical dossier. Learn why having a seasoned local partner is not just a benefit, but a necessity for timely market access and long-term compliance in the UAE.

A European company with a CE-marked device tried to enter the UAE market, expecting a smooth process. They were quickly stopped by two major roadblocks: the requirement for a licensed local representative and the rule that their manufacturing site had to be registered *before* their product. After six months of delays and wasted resources, they had to restart their entire strategy. This episode explains how to avoid this costly scenario.

Key Takeaways:

- Why is pre-registering your manufacturing site a critical first step for MOHAP approval?

- What are the most common documentation errors that lead to rejection?

- How can you choose a local representative in the UAE that protects your long-term interests?

- Can you leverage your UAE submission for other major markets in the Middle East?

- How is AI changing the game for creating and managing technical dossiers for MOHAP?

- What post-market surveillance requirements are unique to the UAE?

- Why might your existing CE mark not be enough for a quick approval?

- What is the strategic difference between using a distributor versus a professional regulatory partner for local representation?

Contact us at [email protected] or visit https://pureglobal.com/ for more information.